On February 24, 2025, Telix Pharmaceuticals Limited filed a Form 6-K announcing the change of its reporting currency to USD. Insights on market impact and compliance included.
Antelope Enterprise Holdings Ltd. amends Form 6-K to clarify auditor changes and correct filing date. Key updates on ARK PRO CPA dismissal and AssentSure PAC engagement.
Explore Galapagos NV's February 2025 Form 6-K, detailing financial filings, recent press releases, and compliance with SEC regulations.
Explore Agora, Inc.'s February 2025 Form 6-K report highlighting CFO Jingbo Wang's insights, filing details, and important exhibits.
Explore Radiopharm Theranostics Limited's Feb 2025 Form 6-K, detailing director interests & securities changes. Key updates for investors.
Explore Bitdeer Technologies Group's February 2025 Form 6-K filing, featuring key financial results and insights for investors. Signed by CEO Jihan Wu.
Eupraxia Pharmaceuticals Inc. submits its February 2025 Form 6-K, ensuring SEC compliance and announcing significant updates. Key insights and press release included.
Discover Super Group's Q4 2024 financial results, $0.04 dividend per share, and 2025 guidance in this Form 6-K report. Key insights for investors and stakeholders.
Explore ZJK Industrial Co., Ltd.'s Form 6-K filing for February 2025, including significant updates and compliance details.
Discover key shareholder updates in Indivior PLC's latest Form 6-K, filed on February 25, 2025. Stay informed on ownership changes affecting your investments.
This report outlines Electra Battery Materials Corp's SEC Form 6-K filed on Feb 25, 2025, detailing significant company updates and compliance information.
Discover key updates in Grifols, S.A.'s February 2025 Form 6-K: Chairman transition, board restructuring, and legal compliance. Essential insights for investors.